Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

The use of doxorubicin (Dox) was severely constrained by dose-dependent side effects, which might be attenuated by combining a “sensitizer” to decrease its cumulative dosage. In this study, it was investigated whether ocotillol could enhance the antiproliferation activity of Dox. MTT assays and xeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongbo, Yu, Pengfei, Bai, Jing, Zhang, Jianqiao, Kong, Liang, Zhang, Fangxi, Du, Guangying, Pei, Shiqian, Zhang, Lixia, Jiang, Yongtao, Tian, Jingwei, Fu, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727205/
https://www.ncbi.nlm.nih.gov/pubmed/23956772
http://dx.doi.org/10.1155/2013/468537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727205/
https://www.ncbi.nlm.nih.gov/pubmed/23956772
http://dx.doi.org/10.1155/2013/468537

Ejemplares similares